Acute promyelocytic leukemia : a clinical guide /: a clinical guide. ([2018])
- Record Type:
- Book
- Title:
- Acute promyelocytic leukemia : a clinical guide /: a clinical guide. ([2018])
- Main Title:
- Acute promyelocytic leukemia : a clinical guide
- Further Information:
- Note: Oussama Abla, Francesco Lo Coco, Miguel A. Sanz, editors.
- Editors:
- Abla, Oussama
Lo Coco, Francesco
Sanz, Miguel A - Contents:
- Intro; Preface; Contents; Contributors; 1: History of Acute Promyelocytic Leukemia; Introduction; A Distinct Entity: "A Special Type of Leukemia" (1957-1987); The Clinical Description; A Controversy About Treatment; A Cytogenetic Signature; A New Paradigm: The Differentiation of Malignant Cells; Abolishing the Dogma of the Irreversible Status of Malignant Cells; An Experimental Approach; A Clinical Approach; All-Trans-Retinoic Acid as a Potential Candidate for Differentiation Therapy of APL; The Dinner that Initiated All-Trans-Retinoic Acid Treatment for APL (1985); Hoops and Hurdles No More ProductIs APL a Pseudo-Leukemia?; Early Relapses with ATRA; Hope for a Curable Disease; Worldwide Enthusiasm; New Clinical Horizons, Unknown Conditions; Nonstandard Regimens; Molecular Defects; First Attempts at Molecular Approaches; Clinical Consequences: Diagnostic and Follow-Up Tools; Toward a Biological Explanation of Oncogenesis and Restoration; Arsenic, a Manchurian Traditional Medicine (1995); A Second Era for Clinicians; A Better Biological Understanding; ATRA-ATO Combination in Patients: From Curable to Cured APL; And Beyond: Lessons and Questions; References 2: Molecular Targets of Treatment in Acute Promyelocytic LeukemiaIntroduction; The Translocation Partners: RARA and PML; The Oncoprotein PML/RARA; Therapeutic Effects of Retinoic Acid in APL; Uncoupling Differentiation and Loss of Clonogenicity Under RA Treatment; RA-Induced PML/RARA Degradation; Role of PML and p53 in theIntro; Preface; Contents; Contributors; 1: History of Acute Promyelocytic Leukemia; Introduction; A Distinct Entity: "A Special Type of Leukemia" (1957-1987); The Clinical Description; A Controversy About Treatment; A Cytogenetic Signature; A New Paradigm: The Differentiation of Malignant Cells; Abolishing the Dogma of the Irreversible Status of Malignant Cells; An Experimental Approach; A Clinical Approach; All-Trans-Retinoic Acid as a Potential Candidate for Differentiation Therapy of APL; The Dinner that Initiated All-Trans-Retinoic Acid Treatment for APL (1985); Hoops and Hurdles No More ProductIs APL a Pseudo-Leukemia?; Early Relapses with ATRA; Hope for a Curable Disease; Worldwide Enthusiasm; New Clinical Horizons, Unknown Conditions; Nonstandard Regimens; Molecular Defects; First Attempts at Molecular Approaches; Clinical Consequences: Diagnostic and Follow-Up Tools; Toward a Biological Explanation of Oncogenesis and Restoration; Arsenic, a Manchurian Traditional Medicine (1995); A Second Era for Clinicians; A Better Biological Understanding; ATRA-ATO Combination in Patients: From Curable to Cured APL; And Beyond: Lessons and Questions; References 2: Molecular Targets of Treatment in Acute Promyelocytic LeukemiaIntroduction; The Translocation Partners: RARA and PML; The Oncoprotein PML/RARA; Therapeutic Effects of Retinoic Acid in APL; Uncoupling Differentiation and Loss of Clonogenicity Under RA Treatment; RA-Induced PML/RARA Degradation; Role of PML and p53 in the Cure of APL Under RA Treatment; Therapeutic Effects of Arsenic Trioxide in APL; ATO-Induced PML NB Reformation and PML/RARA Degradation; RA and ATO Synergy in APL Cure; References; 3: The Leukemic Stem Cell; The Cancer Stem Cell Theory; Defining Stemness in Leukemia The Effects of ATRA and ATO on the Coagulopathy of APLManagement of the Coagulopathy; Platelet Transfusions, Heparin, and Antifibrinolytic Agents; References; 6: Early Death in Acute Promyelocytic Leukemia; Introduction; Definition and Timing of Early Death; Early Death in the Pre-ATRA Era; Early Death in Clinical Trials vs. Population-Based Studies; Causes of Early Death; Bleeding; Infections; Thrombosis; Differentiation Syndrome (DS); Organ Failure; Early Death Risk Factors; Role of ATRA in Early Death; Early Death over Time; Prevention of ED; References … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2018
- Extent:
- 1 online resource
- Subjects:
- 616.99/419
Medicine
Acute myeloid leukemia
Acute myeloid leukemia -- Treatment
HEALTH & FITNESS / Diseases / General
MEDICAL / Clinical Medicine
MEDICAL / Diseases
MEDICAL / Evidence-Based Medicine
MEDICAL / Internal Medicine
Medicine & Public Health
Hematology
Oncology
Acute myeloid leukemia
Medical -- Oncology
Oncology
Hematology
Oncology
Medical -- Hematology
Haematology
Electronic books - Languages:
- English
- ISBNs:
- 9783319642574
3319642561
9783319642567 - Related ISBNs:
- 331964257X
9783319642567 - Notes:
- Note: Includes bibliographical references and index.
Note: Online resource; title from PDF title page (EBSCO, viewed May 02, 2018). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.358046
- Ingest File:
- 01_319.xml